Urso (Ursodiol) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. INDICATIONS AND USAGE URSO 250® and URSO Forte® (ursodiol) tablets are indicated for the treatment of patients with primary biliary cirrhosis. Ursodiol tablets are used to treat primary biliary cholangitis, an autoimmune disorder that causes progressive destruction of the bile ducts in your liver. Ursodiol is also known as ursodeoxycholic acid. Ursodiol may also be used for purposes not listed in this medication guide. Urso package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology. Find clinical guidance on Urso, including indications, dosing, safety, side effects and evidence-based insights for healthcare professionals. Ursodiol is also used to treat primary biliary cirrhosis (PBC). PBC is an autoimmune disorder that causes a patient's liver to have problems and not work properly. This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: URSO prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and URSOside effects. Ursodiol is a type of bile acid that your body naturally forms in small amounts. When you take ursodiol as a medicine, it changes your bile so that cholesterol (a main component of gallstones). Urso, also known as Ursodeoxycholic Acid, is a medication commonly used to treat various liver and gallbladder conditions. It is a bile acid that helps to reduce the amount of cholesterol produced by the liver and dissolve gallstones. Ursodeoxycholic acid (UDCA), also known as ursodiol, is a secondary bile acid, produced in humans and most other species from metabolism by intestinal bacteria. It is synthesized in the liver in some species, and was first identified in bile of bears of genus Ursus, from which its name derived. [8].